Yanagisawa T, Fukuokaya W, Hatakeyama S, Narita S, et al. Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone-sensitive prostate cancer: A multicenter study. Prostate 2024 Oct 17:e24813. doi: 10.1002/pros.24813.
PMID: 39417629